Maturation and Activity of Sterol Regulatory Element Binding Protein 1 Is Inhibited by Acyl-CoA Binding Domain Containing 3

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chen, Yong ^a   Patel, Vishala ^a   Bang, Sookhee ^a   Cohen, Natalie ^a   Millar, John ^a   Kim, Sangwon F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A BINDING DOMAIN CONTAINING 3 PROTEIN; CELL PROTEIN; FATTY ACID SYNTHASE; MESSENGER RNA; PALMITIC ACID; PROTEIN INSIG1; PROTEIN SCAP; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL FRACTIONATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INHIBITION KINETICS; LIPID METABOLISM; LIPOGENESIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL FRACTIONATION; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HOMEOSTASIS; HUMANS; IMMUNOPRECIPITATION; LIPID METABOLISM; LUCIFERASES; MEMBRANE PROTEINS; PROTEIN CONFORMATION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84869108636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049906     Document Type: Article

References (54)

1. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
2. Shimano H, (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452.
3. Espenshade PJ, (2006) SREBPs: sterol-regulated transcription factors. J Cell Sci 119: 973-976.
4. Walker AK, Jacobs RL, Watts JL, Rottiers V, Jiang K, et al. (2011) A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell 147: 840-852.
5. Ferre P, Foufelle F, (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12 Suppl 2: 83-92.
6. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F, (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848.
7. Liu J, Li H, Papadopoulos V, (2003) PAP7, a PBR/PKA-RIalpha-associated protein: a new element in the relay of the hormonal induction of steroidogenesis. J Steroid Biochem Mol Biol 85: 275-283.
8. Fan J, Liu J, Culty M, Papadopoulos V, (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 49: 218-234.
9. Li H, Degenhardt B, Tobin D, Yao ZX, Tasken K, et al. (2001) Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. Mol Endocrinol 15: 2211-2228.
10. Cheah JH, Kim SF, Hester LD, Clancy KW, Patterson SE, et al. (2006) NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51: 431-440.
11. Sohda M, Misumi Y, Yamamoto A, Yano A, Nakamura N, et al. (2001) Identification and characterization of a novel Golgi protein, GCP60, that interacts with the integral membrane protein giantin. J Biol Chem 276: 45298-45306.
12. Zhou Y, Atkins JB, Rompani SB, Bancescu DL, Petersen PH, et al. (2007) The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis. Cell 129: 163-178.
13. Greninger AL, Knudsen GM, Betegon M, Burlingame AL, Derisi JL, (2012) The 3A protein from multiple picornaviruses utilizes the Golgi Adaptor Protein ACBD3 to Recruit PI4KIIIbeta. J Virol.
14. Sasaki J, Ishikawa K, Arita M, Taniguchi K, (2012) ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J 31: 754-766.
15. Elle IC, Simonsen KT, Olsen LC, Birck PK, Ehmsen S, et al. (2011) Tissue- and paralogue-specific functions of acyl-CoA-binding proteins in lipid metabolism in Caenorhabditis elegans. Biochem J 437: 231-241.
16. Furuhashi M, Hotamisligil GS, (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7: 489-503.
17. Gimeno RE, (2007) Fatty acid transport proteins. Curr Opin Lipidol 18: 271-276.
18. Menendez JA, Lupu R, (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777.
19. Ferre P, Foufelle F, (2007) SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 68: 72-82.
20. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS, (1995) Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J Biol Chem 270: 29422-29427.
21. Wang X, Sato R, Brown MS, Hua X, Goldstein JL, (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77: 53-62.
22. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, et al. (2002) Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110: 489-500.
23. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
24. Stahl A, (2004) A current review of fatty acid transport proteins (SLC27). Pflugers Arch 447: 722-727.
25. Kiens B, (2006) Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86: 205-243.
26. Meinnel T, Giglione C, (2008) Protein lipidation meets proteomics. Front Biosci 13: 6326-6340.
27. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, et al. (2008) Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 43: 1-17.
28. Kragelund BB, Knudsen J, Poulsen FM, (1999) Acyl-coenzyme A binding protein (ACBP). Biochim Biophys Acta 1441: 150-161.
29. Landrock D, Atshaves BP, McIntosh AL, Landrock KK, Schroeder F, et al. (2010) Acyl-CoA binding protein gene ablation induces pre-implantation embryonic lethality in mice. Lipids 45: 567-580.
30. Vock C, Biedasek K, Boomgaarden I, Heins A, Nitz I, et al. (2010) ACBP knockdown leads to down-regulation of genes encoding rate-limiting enzymes in cholesterol and fatty acid metabolism. Cell Physiol Biochem 25: 675-686.
31. Mandrup S, Sorensen RV, Helledie T, Nohr J, Baldursson T, et al. (1998) Inhibition of 3T3-L1 adipocyte differentiation by expression of acyl-CoA-binding protein antisense RNA. J Biol Chem 273: 23897-23903.
32. Franch J, Knudsen J, Ellis BA, Pedersen PK, Cooney GJ, et al. (2002) Acyl-CoA binding protein expression is fiber type- specific and elevated in muscles from the obese insulin-resistant Zucker rat. Diabetes 51: 449-454.
33. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS, (2001) Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem 276: 4365-4372.
34. Krycer JR, Sharpe LJ, Luu W, Brown AJ, (2010) The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab 21: 268-276.
35. Taghibiglou C, Martin HG, Lai TW, Cho T, Prasad S, et al. (2009) Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 15: 1399-1406.
36. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, et al. (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119: 1201-1215.
37. Lee JN, Ye J, (2004) Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J Biol Chem 279: 45257-45265.
38. Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, et al. (2007) Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282: 11687-11695.
39. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, et al. (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24: 1403-1417.
40. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, et al. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285: 33959-33970.
41. Le HS, Muhleisen TW, Djurovic S, Ferno J, Ouriaghi Z, et al. (2010) Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry 15: 463-472.
42. Raeder MB, Ferno J, Vik-Mo AO, Steen VM, (2006) SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem 289: 167-173.
43. Spell C, Kolsch H, Lutjohann D, Kerksiek A, Hentschel F, et al. (2004) SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele. Dement Geriatr Cogn Disord 18: 245-249.
44. Karasinska JM, Hayden MR, (2011) Cholesterol metabolism in Huntington disease. Nat Rev Neurol 7: 561-572.
45. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
46. Tang JJ, Li JG, Qi W, Qiu WW, Li PS, et al. (2011) Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab 13: 44-56.
47. Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, et al. (2006) Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res 66: 5934-5940.
48. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, et al. (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A 97: 3450-3454.
49. De SE, Brusselmans K, Heyns W, Verhoeven G, Swinnen JV, (2003) RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 63: 3799-3804.
50. Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP, (2005) Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene 24: 39-46.
51. Yabe D, Brown MS, Goldstein JL, (2002) Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci U S A 99: 12753-12758.
52. Morrison WR, Smith LM, (1964) Preparation of Fatty Acid Methyl Esters and Dimethylacetals from Lipids with Boron Fluoride-Methanol. J Lipid Res 5: 600-608.
53. Lee WN, Bassilian S, Guo Z, Schoeller D, Edmond J, et al. (1994) Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. Am J Physiol 266: E372-E383.
54. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ, (2009) Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10: 405-418.